Bernhard Fasching

Bernhard Fasching currently serves as Vice President, Chemistry at Monte Rosa Therapeutics, a position held since September 2019, following roles as Senior Director and Director of Chemistry within the same organization. Previous experience includes serving as Director of Chemistry at Ridgeline Therapeutics and holding positions as a Principal Scientist in Medicinal Chemistry. Additional roles encompass senior consultancy at Sequel Blu GmbH and the position of VP of Chemistry at Endogena Therapeutics, Inc. Bernhard Fasching's earlier career includes significant contributions at Roche as a Scientist and Lab Head, as well as a post-doctoral research fellowship at Memorial Sloan-Kettering Cancer Center. The academic journey culminated in a Diplom Ingenieur (Master equivalent) in Biotechnology and Organic Chemistry from Technische Universität Graz.